CNS Vital Signs is a world leader in the design and development of neurocognitive and behavioral assessment tools and technologies. They provide clinicians and researchers with leading-edge technologies for improved neurocognitive and behavioral evaluation and management capabilities.
An Australian company established in 1989 by Daniel Weber DSC., PhD and Wilhemina Hoedeman. Panaxea™ is seen as an innovative company, using herbal formulations, individual botanicals and botanical isolates for the treatment of a wide variety of diseases. Its primary focus is in oncology, where Prof. Weber has done extensive research, publishing peer-reviewed papers and a number of widely regarded books on the subject. Panaxea™ formulations are unique and are registered as medicines in Australia.